Viewing Study NCT06722950


Ignite Creation Date: 2025-12-24 @ 5:14 PM
Ignite Modification Date: 2025-12-24 @ 5:14 PM
Study NCT ID: NCT06722950
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-12-09
First Post: 2024-10-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase II Clinical Study of AC591 in Preventing Oxaliplatin-Induced Peripheral Neuropathy
Sponsor: Shandong New Time Pharmaceutical Co., LTD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module